COMMUNIQUÉS West-GlobeNewswire

Genetic Technologies Announces Offering of Approximately USD 1.2 Million of American Depository Shares
22/05/2019
MELBOURNE, Australia, May 22, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company, today announced that it has entered into a securities [...]
Amedisys to Present at the Jefferies 2019 Healthcare Conference
22/05/2019
BATON ROUGE, La., May 22, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief [...]
OSE Immunotherapeutics to Host Key Opinion Leader Meeting on Novel Treatments in Non-Small Cell Lung Cancer
22/05/2019
Meeting Scheduled for May 30, 2019 in New York City NANTES, France, May 22, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE), today announced that it will host a Key Opinion Leader ( [...]
Be The Match BioTherapies® and Kiadis Pharma Announce Strategic Collaboration to Accelerate Patient Access to Haploidentical Stem Cell Therapies
22/05/2019
Collaboration will support Phase III clinical trial of cell therapy product ATIR101(TM) for blood cancers MINNEAPOLIS & AMSTERDAM, May 22, 2019 - Be The Match BioTherapies ®, an organization offering solutions for [...]
Emerald Health Therapeutics nomme un directeur de l'exploitation
22/05/2019
Sean Rathbone apporte sa grande expertise en matière de projets d'investissement, de direction opérationnelle et de gestion des processus d'entreprise VICTORIA, Colombie-Britannique, 22 mai 2019 (GLOBE NEWSWIRE) -- [...]
Abeona Therapeutics annonce l'approbation de la FDA pour la demande d'investigation d'un nouveau médicament pour la thérapie génique ABO‑202 concernant la maladie CLN1
22/05/2019
NEW YORK et CLEVELAND, 22 mai 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), leader pleinement intégré dans la thérapie génique et la cytothérapie, a annoncé aujourd'hui que la Société est autorisée [...]
Terranueva concludes a letter of intent with SQDC
22/05/2019
MONTREAL, May 22, 2019 (GLOBE NEWSWIRE) -- Terranueva Corporation (CSE: TEQ) (“Terranueva” or the “Company”) is pleased to announce the signing of a letter of intent with la Société québécoise du cannabis (SQDC) under [...]
Terranueva conclut une lettre d’intention avec la SQDC
22/05/2019
MONTRÉAL, 22 mai 2019 (GLOBE NEWSWIRE) -- Corporation Terranueva (CSE: TEQ) (« Terranueva » ou la « Société ») est heureuse d’annoncer la signature d’une lettre d’intention avec la Société québécois du cannabis (SQDC) [...]
Portola Pharmaceuticals Announces New Analysis from the ANNEXA-4 Study of its Factor Xa Inhibitor Reversal Agent Andexxa® in Patients with Spontaneous (Non-Traumatic) Intracranial Hemorrhage
22/05/2019
– Excellent or Good Hemostasis Achieved in 79% of Evaluable Patients with Spontaneous Intracranial Hemorrhage – – Data Featured in an Oral Presentation at the 5 th European Stroke Organisation Conference – SOUTH SAN [...]
Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States
22/05/2019
PARIS and CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for age-related diseases, today [...]
Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences
22/05/2019
MOORESTOWN, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, today announced that Chairman and CEO, [...]
Vistin Pharma ASA: Minutes from the annual general meeting 2019
22/05/2019
Oslo, Norway, 22 May 2019 Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 22 May 2019. All matters were resolved as proposed in the call for the annual general [...]
DiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29, 2019
22/05/2019
MINNEAPOLIS, May 22, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that it will be participating in the 16th Annual Craig-Hallum Institutional Investor Conference on Wednesday, May [...]
Coherus BioSciences Management to Present at Jefferies 2019 Global Healthcare Conference
22/05/2019
REDWOOD CITY, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will present at the Jefferies 2019 Global Healthcare Conference in New York City on [...]
New York City Ichan School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International Consortium” to Develop Treatment of Opioid Addiction
22/05/2019
MediPharm Labs enters major U.S. led opioid clinical research trial to develop IP and exclusively manufacture CBD gelcaps TORONTO, May 22, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: [...]
SetPoint Medical to Present at Guggenheim 2019 MedTech Disruptors Summit
22/05/2019
VALENCIA, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, announced today that Murthy Simhambhatla, Ph.D., [...]
Patent Issued for a New Type of Transparent Radiation Shielding for the Medical and Nuclear Industries
22/05/2019
WAYNESBORO, Va., May 22, 2019 (GLOBE NEWSWIRE) -- Radium Incorporated ( Radium ) announced today that it has been issued a patent from the United States Patent and Trademark Office for a new type of transparent [...]
Wildflower Brands Signs Distribution Agreement for South Africa
22/05/2019
VANCOUVER, British Columbia, May 22, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “Company”) is pleased to announce the signing of an exclusive distribution agreement [...]
Anchiano Therapeutics Reports First Quarter 2019 Financial Results
22/05/2019
– Closed $30.5 million U.S. Initial Public Offering in February 2019 – CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”), a pivotal-stage [...]

Pages